Co-op IT Advanced Applications, AI - 2 roles
Boehringer Ingelheim2 months ago
Athens, GA, USAIntern
Responsibilities
- Collaborate with business partners to identify application and process improvement opportunities.
- Propose IT-centered enhancements, technology use cases, and solutions.
- Develop and execute pilot projects with the local IT team using relevant technologies and Agile methodologies.
- Document solution designs and transfer knowledge and lessons learned to the local IT team.
- Support business partners with technology-related needs.
Requirements
- At least two years of software development experience, preferably with ASP.NET, Java, or Python.
- Current undergraduate, graduate, or professional student in good academic standing.
- At least 12 completed credit hours in a related major or related coursework.
- Minimum cumulative GPA of 3.0 on a 4.0 scale.
- Major related to the internship field.
- Legally authorized to work in the United States without restriction.
- At least 18 years of age and willing to complete a drug test and post-offer physical if required.
- Experience with artificial intelligence or data science is preferred.
- Experience with cloud-based systems is preferred.
- Ability to communicate technology-related information to nontechnical audiences and collaborate with colleagues globally.
Benefits
- Full-time co-op lasting at least four months, with possible extension to six months based on business needs.
- On-site schedule of at least three days per week in Athens, Georgia, requiring residence within commuting distance for the co-op.
- Opportunities to collaborate internationally and contribute to company operations and decision-making.
- Competitive compensation and benefits, with support for networking, mobility, meaningful work, work-life balance, and a healthy working environment.
About Boehringer Ingelheim
Boehringer Ingelheim develops and manufactures prescription medicines for humans and animal health products, and provides biopharmaceutical contract manufacturing services. The family-owned company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. Its portfolio spans areas such as cardiovascular and metabolic diseases, respiratory disorders, oncology, and vaccines for livestock and companion animals, with products marketed globally.